The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 102.00
Ask: 106.00
Change: -1.50 (-1.42%)
Spread: 4.00 (3.922%)
Open: 105.50
High: 105.50
Low: 104.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

16 Mar 2015 07:00

RNS Number : 3930H
Intercede Group PLC
16 March 2015
 

 

16 March 2015

 

California Industry Veteran Joins Intercede Board of Directors

Rob Chandhok Appointed as Non-Executive Director of Intercede Group plc

 

Cybersecurity expert Intercede today announced that Rob Chandhok will join the Board of Intercede effective 1 April 2015 as an independent non-executive director.

 

Rob Chandhok is a technology strategist who is well versed in creating business value in the mobile and Internet of Things markets. He is currently President, Chief Operating Officer and member of the Board of Helium Systems Inc., a San Francisco based IoT startup. Prior to this he was President of Qualcomm Interactive Platforms and Senior Vice President of Qualcomm Technologies. In this role Chandhok was responsible for the strategies underlying the development and productisation of Qualcomm's mobile software technologies, and the integration of mobile operating systems and the applications written to them with the company's industry-leading chipsets. In his capacity as the President of the Qualcomm Innovation Center, he also served on the board of the Symbian Foundation.

 

Chandhok was most recently associated with Qualcomm's developments in the Internet of Things. He championed an industry initiative called AllJoyn, which is an open source project driving interoperability between over 100 companies in the Allseen Alliance, especially in home consumer electronics.

 

Intercede CEO Richard Parris said: "I am delighted that Rob has chosen to join the Intercede Board. His considerable experience and background in software and embedded systems makes him the ideal person to see the value of the Intercede secure mobility and IoT proposition. His participation on the Intercede Board will greatly assist Intercede in shaping and executing our growth strategy."

 

Rob Chandhok added: "I believe Intercede's technology for managing digital trust on embedded devices is critical to securing modern applications in the Cloud. The Intercede platform has horizontal applicability across a wide range of mobile and IoT ecosystems and I am pleased to be invited to help drive the strategy for Intercede's exploitation of this very large opportunity."

 

The following information regarding Ravinder (Rob) Paul Chandhok's (aged 52) appointment is required to be disclosed under Schedule 2g of the AIM Rules for Companies:

 

Other directorships held within the last five years:

 

Qualcomm Connected Experiences Israel Ltd.;

Qualcomm Connected Experiences Switzerland AG;

Qualcomm Connected Experiences, Inc.;

Qualcomm Labs, Inc.;

Sierra Acquisition Corporation;

TransCella, Inc.;

Within Technology, Inc.

 

 

ENQUIRIES

 

Intercede Group plc Tel: 01455 558111

Richard Parris, Chairman & Chief Executive

Andrew Walker, Finance Director

 

finnCap Ltd Tel: 020 7220 0500

Stuart Andrews, Corporate Finance

Joanna Weaving, Corporate Broking

 

 

About Intercede:

 

Intercede is a software and service company specialising in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity.

 

Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years.

 

Intercede's MyID software is an identity and credential management system that enables organisations to create and assign trusted digital identities to employees, citizens and machines and in turn allows secure access to services, facilities, information and networks. MyID adheres to international standards, while remaining simple enough to be deployed onto consumer devices such as smartphones, tablets and other devices in the Internet of Things.

 

In 2015 Intercede launched MyTAM; enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. The cloud-based service provides a cost-effective and convenient way for developers and corporations to protect their apps and users' sensitive data.

 

For more information visit: www.intercede.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABGGDXSSBBGUX
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.